Document is current

Weiterer EGFR-Antikörper in der Erstlinientherapie des NSCLC getestet

Crossref DOI link: https://doi.org/10.1007/s15015-015-2217-z

Published Online: 2015-12-19

Published Print: 2015-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy